RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Great to work together with many colleagues as we outline current challenges in treating metastatic prostate cancer and s…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @DrChoueiri: Our own @DanaFarber_GU @DanaFarber Dr. Beltran! Thank you @NatureCancer for highlighting #WomenInScience !
RT @DrChoueiri: Our own @DanaFarber_GU @DanaFarber Dr. Beltran! Thank you @NatureCancer for highlighting #WomenInScience ! https://t.co/E8O…
RT @DrChoueiri: Our own @DanaFarber_GU @DanaFarber Dr. Beltran! Thank you @NatureCancer for highlighting #WomenInScience ! https://t.co/E8O…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @DrChoueiri: Our own @DanaFarber_GU @DanaFarber Dr. Beltran! Thank you @NatureCancer for highlighting #WomenInScience ! https://t.co/E8O…
RT @DrChoueiri: Our own @DanaFarber_GU @DanaFarber Dr. Beltran! Thank you @NatureCancer for highlighting #WomenInScience !
Our own @DanaFarber_GU @DanaFarber Dr. Beltran! Thank you @NatureCancer for highlighting #WomenInScience !
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
RT @mishabeltran: Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so…
Thank you @NatureCancer for highlighting our paper and for celebrating women in science! I continue to be inspired by so many brilliant women in the field #WomenInScience #WomenAndGirlsInScience
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
RT @NatureCancer: 🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://…
🌟"Accelerating precision medicine in metastatic prostate cancer" by @mishabeltran &Co @NatureCancer Find it at: https://t.co/FpUdncEJia #11F #WomenInScience #WomenAndGirlsInScience @UN_Women https://t.co/SbJCjizw9n
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @quimmateo: Our perspective paper "Accelerating #precisionmedicine in metastatic #prostatecancer" @NatureCancer is available here: https…
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @NatRevUrol: A nice Perspectives on precision medicine in #prostatecancer from our friends over at@NatureCancer https://t.co/YdcrooI3LF
A nice Perspectives on precision medicine in #prostatecancer from our friends over at@NatureCancer https://t.co/YdcrooI3LF
RT @PCF_Science: For those without a Nature Cancer subscription, here is a link to view the paper we are discussing for #ProstateJC: https…
RT @PCF_Science: For those without a Nature Cancer subscription, here is a link to view the paper we are discussing for #ProstateJC: https…
RT @mishabeltran: Great to work together with many colleagues as we outline current challenges in treating metastatic prostate cancer and s…
RT @PCF_Science: For those without a Nature Cancer subscription, here is a link to view the paper we are discussing for #ProstateJC: https…
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @PCF_Science: For those without a Nature Cancer subscription, here is a link to view the paper we are discussing for #ProstateJC: https…
RT @PCF_Science: For those without a Nature Cancer subscription, here is a link to view the paper we are discussing for #ProstateJC: https…
RT @PCF_Science: For those without a Nature Cancer subscription, here is a link to view the paper we are discussing for #ProstateJC: https…
RT @PCF_Science: For those without a Nature Cancer subscription, here is a link to view the paper we are discussing for #ProstateJC: https…
RT @PCF_Science: For those without a Nature Cancer subscription, here is a link to view the paper we are discussing for #ProstateJC: https…
RT @PCF_Science: #ProstateJC is starting NOW! For the next 48 hours, we will be discussing the recent @NatureCancer paper on accelerating…
RT @DrChoueiri: Don’t miss this event with @quimmateo and @DanaFarber_GU @mishabeltran — @PCF_Science is one of the best sources for prosta…
For those without a Nature Cancer subscription, here is a link to view the paper we are discussing for #ProstateJC: https://t.co/NleqMau8k7
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @DrChoueiri: Don’t miss this event with @quimmateo and @DanaFarber_GU @mishabeltran — @PCF_Science is one of the best sources for prosta…
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @DrChoueiri: Don’t miss this event with @quimmateo and @DanaFarber_GU @mishabeltran — @PCF_Science is one of the best sources for prosta…
RT @PCF_Science: #ProstateJC is starting NOW! For the next 48 hours, we will be discussing the recent @NatureCancer paper on accelerating…
RT @PCF_Science: #ProstateJC is starting NOW! For the next 48 hours, we will be discussing the recent @NatureCancer paper on accelerating…
RT @DrChoueiri: Don’t miss this event with @quimmateo and @DanaFarber_GU @mishabeltran — @PCF_Science is one of the best sources for prosta…
RT @DrChoueiri: Don’t miss this event with @quimmateo and @DanaFarber_GU @mishabeltran — @PCF_Science is one of the best sources for prosta…
Don’t miss this event with @quimmateo and @DanaFarber_GU @mishabeltran — @PCF_Science is one of the best sources for prostate cancer education, research and knowledge ! #ProstateJC @NatureCancer
#ProstateJC is starting NOW! For the next 48 hours, we will be discussing the recent @NatureCancer paper on accelerating precision medicine in metastatic #ProstateCancer. Please join us! https://t.co/kgzrA7YSkO
RT @neerajaiims: Sounds like an excellent learning opportunity from the leaders @quimmateo @mishabeltran #ProstateCancer Looking forward to…
RT @soulehoward1: Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm
Towards precision medicine in metastatic prostate cancer. #prostatecancer https://t.co/o5dnRPqLGf
RT @neerajaiims: Sounds like an excellent learning opportunity from the leaders @quimmateo @mishabeltran #ProstateCancer Looking forward to…
Sounds like an excellent learning opportunity from the leaders @quimmateo @mishabeltran #ProstateCancer Looking forward to following this tweeter discussion on Monday morning. Thanks for organizing @PCF_Science @AndreaMiyahira @soulehoward1
RT @soulehoward1: Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm https://t.co/pVFcy…
RT @soulehoward1: Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @ThePCCTC: An exciting @PCF_Science #ProstateJC for sure! #prostatecancer #precisionmedicine
An exciting @PCF_Science #ProstateJC for sure! #prostatecancer #precisionmedicine
RT @soulehoward1: Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @soulehoward1: Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @soulehoward1: Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm
RT @soulehoward1: Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm
RT @soulehoward1: Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm
RT @soulehoward1: Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm https://t.co/pVFcy…
Please join our Twitter journal club addressing #PrecisionMedicine for #ProstateCancer therapy. #pcsm
RT @kirsiketola: Join the Twitter-based 48-hour prostate cancer journal club by the PCF Science on Nov 30 👇 https://t.co/5LvKBjcBtE
Join the Twitter-based 48-hour prostate cancer journal club by the PCF Science on Nov 30 👇
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…
RT @PCF_Science: Our next 48-hour #ProstateJC will start on Nov 30 @ 10am ET. We will be discussing the recent @NatureCancer paper on ac…